Research Interests

Description:
Dr. Conti is board certified in Nuclear Medicine specializing in diagnostic imaging applications in oncology. He is an expert in the clinical use of positron emission tomography (PET) in the diagnosis, staging and treatment monitoring of cancer. His research interests include the development of new radiolabeled imagining agents for use in the diagnosis of cancer and infectious disease and evaluation of the effects of gene therapy on tumors.
Categories:
  • Development of new radioactive biological tracers for diagnosis of cancer and infectious disease using positron emission tomography

Clinical Interests

Categories:
  • Diagnostic Radiology
  • Oncology applications of positron emission tomography
  • Nuclear Radiology
  • PET Imaging
  • BioImaging

HISTORY & EDUCATION

Degrees
  • Cornell University, PHD, 1985
  • Cornell University Medical College, MD, 1985
Internships
  • St. Lukes Hospital; Surgery, 1985 – 1986
Residencies
  • Johns Hopkins Hospital - Radiology, 1986 – 1989
Fellowships
  • Johns Hopkins Hospital - Nuclear Medicine, 1990 – 1991
Board Certification
  • American Board of Radiology, 1992
  • American Board of Nuclear Medicine, 1991

MEMBERSHIPS & AFFILIATIONS

Memberships
  • Society of Nuclear Medicine
  • American College of Radiology
  • American College of Nuclear Physicians
Clinical Affiliation
  • USC Care Medical Group
    USC University Hospital
    USC/Norris Cancer Hospital

PUBLICATIONS

  • Conti, PS, Sordillo PP, Sordillo EM, and Schmall B. Tumor localization of the metabolically trapped radiolabeled substrates 2-deoxy-D-glucose and aminocyclopentanecarboxylic acid in human melanoma heterotransplants. Amer J Clin Oncol 9: 537-540, 1986.
  • Conti PS, Keppler J and Halls JM. Positron emission tomography: A financial and operational analysis. Amer J Roentg 162: 1279-1286, 1994.
  • Conti PS, Alauddin MM, Fissekis J, Schmall B and Watanabe KA. Synthesis of carbon-11 labeled 2'-fluoro-5-methyl-1-D-arabinofuranosyluracil (FMAU): A potential nucleoside analogue for in vivo study of cellular proliferation with PET. Nucl Med Biol 22: 783-789, 1995
  • Conti PS, Lilien DL, Grafton ST, Bading JR, Keppler J and Hawley K. PET and (18F)-FDG: A clinical update. Nucl Med Biol 23: 717-735, 1996
  • Powars DR, Conti pS, Wong W-Y, Groncy P, Hyman C, Smoth E, Ewing N, Keenan RR, Zee C-S, Harold Y, Hiti A, Teng E, Chan LS. Cerebra vasculopathy in sickle cell anemia: Diagnostic utility of positron emission tomography (PET) and magnetic resonance imaging (MRI). Blood 93: 1-10, 1999.

Direct link to profile: http://keck.usc.edu/profiles?facid=221